Mabel M Ryder

发表

Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression

James A. Fagin, T. Hohl, E. Pamer, 2013, PloS one.

Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer.

J. Ricarte-Filho, J. Fagin, R. Ghossein, 2008, Endocrine-related cancer.

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

T. Giordano, Y. Nikiforov, M. Medvedovic, 2011, Oncogene.

123I Scan With Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry Before 131I Treatment of Metastatic Thyroid Cancer.

G. Johnson, C. Hruska, T. Bogsrud, 2020, Clinical nuclear medicine.

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

J. Sosman, M. Dwyer, B. Kaffenberger, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

M. Rivera, R. Smallridge, T. Sebo, 2017, The Journal of clinical endocrinology and metabolism.

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.

S. Larson, N. Rosen, D. Chakravarty, 2011, The Journal of clinical investigation.

Foundation OneTM Genomic Interrogation of Thyroid Cancers in Patients with Metastatic Disease Requiring Systemic Therapy.

R. Smallridge, John C. Morris, K. Bible, 2020, The Journal of clinical endocrinology and metabolism.

Management of Immunotherapy-Related Toxicities, Version 1.2019.

Matthew J. Frigault, M. Wahidi, J. Sosman, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance

M. Castro, J. Brito, I. Hay, 2015, Cancer.

Survival benefit of endocrine dysfunction following immune checkpoint inhibitors for nonthyroidal cancers

A. Kotwal, Mabel M Ryder, Mabel Ryder, 2021, Current opinion in endocrinology, diabetes, and obesity.

Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts

Brian C. Netzel, James L. Miller, J. Copland, 2018, The Journal of clinical endocrinology and metabolism.

Treatment of lateral neck papillary thyroid carcinoma recurrence after selective lateral neck dissection

D. Farley, G. Thompson, Mabel M Ryder, 2019, Surgery.

Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study.

M. Castro, D. Dean, V. Fatourechi, 2016, Thyroid : official journal of the American Thyroid Association.

Promises and Perils of Molecularly Targeted Therapeutics in Anaplastic Thyroid Cancer.

K. Bible, Mabel M Ryder, A. Chintakuntlawar, 2016, Journal of oncology practice.

J. Wolchok, M. Callahan, M. Postow, 2014, Endocrine-related cancer.

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.

J. Fagin, R. Ghossein, J. Knauf, 2013, Endocrine-related cancer.

Comprehensive Lateral Neck Dissection in Papillary Thyroid Carcinoma may Reduce Lateral Neck Recurrence Rates

D. Farley, G. Thompson, Mabel M Ryder, 2018, Annals of Surgical Oncology.

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.

Matthew J. Frigault, J. Sosman, M. Ernstoff, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

PD-L1 Inhibitor-Induced Thyroiditis is Associated with Better Overall Survival in Cancer Patients.

A. Kotwal, L. Kottschade, Mabel M Ryder, 2019, Thyroid : official journal of the American Thyroid Association.

Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.

K. Bible, Mabel M Ryder, Nicole M. Iñiguez-Ariza, 2017, Thyroid : official journal of the American Thyroid Association.

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

D. Fraker, K. Goodman, M. Soulen, 2021, Pancreas.

Added value of mass characteristic frequency to 2-D shear wave elastography for differentiation of benign and malignant thyroid nodules.

Jeremy M. Webb, M. Fatemi, A. Alizad, 2022, Ultrasound in medicine & biology.

Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases

Karra A. Jones, A. Bellizzi, A. Raghunathan, 2020, Diagnostic Pathology.

NCCN: Continuing Education

Matthew J. Frigault, J. Sosman, M. Ernstoff, 2019 .

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.

M. Cabanillas, C. Jimenez, Mabel M Ryder, 2019, Endocrine reviews.